Purchases and Sales Made in Q4 2024 in Karyopharm Therapeutics Inc. (KPTI)
This table provides information about the institutional ownership of Karyopharm Therapeutics Inc. (KPTI) during Q4 2024. The information is specifically focused on institutions that hold shares of Karyopharm Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Palo Alto Investors LP
Palo Alto, CA |
SELL
|
- |
-195K- 3.83% |
$117K - $193K
|
4.91M
$2.94M
|
|
|
Feb 14, 2025
Q4 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-818K- 78.07% |
$491K - $810K
|
230K
$138K
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.11M- 80.07% |
$666K - $1.1M
|
276K
$166K
|
|
|
Feb 14, 2025
Q4 2024
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-3.46M- 62.35% |
$2.08M - $3.42M
|
2.09M
$1.25M
|